The university announced Tuesday that it will receive the grants from the National Institutes of Health.

Microbiology and immunology professor John Tavis last year published research demonstrating a way to measure and block an enzyme to stop the hepatitis B virus from spreading. The grant money will help extend that research.

Current drugs can treat hepatitis B but not cure it. The majority of liver cancer cases worldwide are caused by the disease.